Evidence map›Paper›PMID 23770670›Full record

ArticleThe Journal of biological chemistry2013

Aryl hydrocarbon receptor activation by dioxin targets phosphoenolpyruvate carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly(ADP-ribose) polymerase (TiPARP).

Silvia Diani-Moore, Sheng Zhang, Payal Ram, Arleen B Rifkind

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Forced Self-Modification Assays as a Strategy to Screen MonoPARP Enzymes.SLAS discovery : advancing life sciences R & D · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Silvia Diani-MooreDepartment of Pharmacology, Weill Cornell Medical College, New York, New York 10065, USA.
Sheng Zhang
Payal Ram
Arleen B Rifkind
Cornell University · USNew York State College of Agriculture & Life Sciences · US

Funding

ARACHIDONATE PRODUCTS IN DIOXIN &PCB TOXICITYR01ES003606 · NIEHS · WEILL MEDICAL COLL OF CORNELL UNIV · PI RIFKIND, ARLEEN B. · 1985 to 2011
$4.8M
NIEHS NIH HHS ES-03606NIEHS NIH HHS R01 ES003606
6 · The paper itself

Abstract

Effects of the environmental toxin and carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) include a wasting syndrome associated with decreased gluconeogenesis. TCDD is a potent activator of the aryl hydrocarbon receptor (AHR), a ligand activated transcription factor. The relationship between gene activation by the AHR and TCDD toxicities is not well understood. We recently identified a pathway by which the AHR target gene TiPARP (TCDD-inducible poly(ADP-ribose) polymerase) contributes to TCDD suppression of transcription of phosphoenolpyruvate carboxykinase (PEPCK), a key regulator of gluconeogenesis, by consuming NAD(+) and decreasing Sirtuin 1 activation of the peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), a transcriptional activator of PEPCK. We report here that TCDD-induced TiPARP also targets PEPCK for ADP-ribosylation. Both cytosolic and mitochondrial forms of PEPCK were found to undergo ADP-ribosylation. Unexpectedly, AHR suppression also enhanced ADP-ribosylation and did so by a poly(ADP-ribose) polymerase-independent mechanism. This report 1) identifies ADP-ribosylation as a new posttranslational modification for PEPCK, 2) describes a pathway by which transcriptional induction of TiPARP by the AHR can lead to a downstream posttranslational change in a TCDD target protein (PEPCK), and 3) reveals that the AHR exerts complex, previously unidentified modulatory effects on ADP-ribosylation.

Indexed as

Adenosine Diphosphate RiboseAmino Acid SequenceAnimalsBlotting, WesternCell Line, TumorCells, CulturedChick EmbryoChickensGene ExpressionHEK293 CellsHepatocytesHep G2 CellsHumansMolecular Sequence DataPhosphoenolpyruvate Carboxykinase (ATP)Poly(ADP-ribose) PolymerasesAdenosine Diphosphate RibosePhosphoenolpyruvate Carboxykinase (ATP)Poly(ADP-ribose) PolymerasesPolychlorinated DibenzodioxinsReceptors, Aryl HydrocarbonADP-ribosylationAryl Hydrocarbon ReceptorDioxinLiverPhosphoenolpyruvate CarboxykinaseTiPARP

Identifiers

PMID23770670
PMCPMC3724612
OpenAlexW2074267274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.